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Patients treated for COVID-19 pneumonia in the Intensive Care Unit (ICU) often experience 
long periods of ventilation, neuromuscular blockade and sedation (1). Previous research has 
demonstrated that patients with similar clinical journeys often have poor long-term health 
related quality of life (HRQoL) (2). At present there are limited data describing the long-term 
outcomes of critically ill COVID-19 survivors. To address this, we report on early data 
obtained at our ICU follow-up programme in a single centre.   
 
Patients are routinely invited to our multi-disciplinary ICU follow-up clinic between 12-16 
weeks post discharge (3). Information on the format of the clinic is available in S1.  Data 
was collected following attendance at a virtual clinic.  HRQoL was measured using the 
EQ-5D-5L; this tool comprises two sections: a five-question descriptive component which 
explores health domains and a visual analogue scale about HRQoL. Each question has five 
possible answers. These answers produce a five-digit sequence which is used to determine 
a Health Utility Score (HUS). A HUS of 1 equates to the best health state possible, 0 with 
death and a negative HUS equates to a state worse than death (4). We also examined 
return to employment. Ethical approval was granted by The North West (Liverpool Central) 
Research Ethics Committee, REC Number: 17/NM/0199.  All patients provided consent.   
 
From March 14th, 2020 until April 28th, 2020, 51 patients required invasive mechanical 
ventilation for COVID-19 pneumonia in our ICU. All cases were confirmed with reverse RT-
PCR assay for SARS COV-2, except for one patient who died prior to a sputum sample 
being obtained. Complete records of 43 patients were available for review. Of the 43 
patients examined, 33 (77%) were male and the median age was 57 (IQR:52.5-65.5). 27 
(63%) patients had 1 or more comorbidity.  ICU mortality was 33%, median ICU length of 
stay 17.9 days (IQR:7.4-26.5) and the median duration of ventilation was also 17.9 (IQR:6.5-
24).  Most (93%) patients developed severe ARDS during their admission (P: F or S:F ratio 
<13.3kPa) and 37 (86%) received neuromuscular blockade with a median of 6 (IQR: 2.5-11) 
days paralysis. Sixty percent of patients were proned at least once (Table 1). 
 
Of the 30 survivors, 24 (80%) attended follow up. Outcome data was available from 21 
patients; one patient declined inclusion; one was readmitted to hospital following their 
consultation and could not participate in the research and one agreed to participate but 
could not be contacted following clinic.  The median HUS was 0.752 (IQR:0.627-0.837).  
Fifteen patients were employed pre-ICU. When reviewed at follow-up, 7 (47%) had returned 
to work and 1 (7%) had taken voluntary retirement.  One (7%) patient was planning to return 
to work in the week following clinic attendance. New disability including breathlessness were 
reported as impacting on employability; a small number of patients described they were 
unable to return to work due to COVID-19 employment restrictions.  Fourteen (67%) patients 
complained of new pain; 29% of pain was classified as severe or extreme.   
 
This cohort had a significant burden of acute illness requiring prolonged mechanical 
ventilation and high rates of neuromuscular blockade.  Despite this, we report meaningful 
early recovery including increased return to employment in a single centre, from a small 
sample (5).  However, caution should be taken with the interpretation of these outcomes, as 
employment status can fluctuate following critical illness (5). Furthermore, HRQoL was 
similar to a previous ARDS cohort (Median HUS, 0.77) and better than a previous cohort of 
survivors from our own centre (Median HUS, 0.29) (3, 6-7). Two thirds of patients 
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Demographic		 n=43		
Age,	Year,	Median	(IQR)		 57	(52.5-65.5)	
Gender,	Male	(%)	 33	(77%)	
Comorbidity:	 	
			Diabetes	 9	(21%)	
			Respiratory	 8	(19%)	
			Cardiovascular	(including	hypertension)	 13	(30%)	
			Other	(Cancer,	Liver	Disease,	CKD)	 12	(28%)	
Length	of	ICU	Stay,	Days,	Median	(IQR)		 17.9	(7.4-26.5)	
Mechanical	Ventilation	Duration,	Days,	Median	(IQR)	 17.9	(6.5-24)	
Diagnosis	of	severe	ARDS	(%)	 40	(93%)	
Neuromuscular	blockage	administration	(%)	 37	(86%)	
Prone	Position	(%)	 26	(60%)	
  
Table	One:	ICU	Cohort	Demographics	
	
 
 
